- Home
- BMR vs VRCA Comparison
BMR vs VRCA Comparison
Compare BMR & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- VRCA
- Stock Information
- Founded
- BMR 2009
- VRCA 2013
- Country
- BMR Israel
- VRCA United States
- Employees
- BMR N/A
- VRCA 71
- Industry
- BMR Computer Software: Prepackaged Software
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- VRCA Health Care
- Exchange
- BMR Nasdaq
- VRCA Nasdaq
- Market Cap
- BMR 54.2M
- VRCA 58.7M
- IPO Year
- BMR 2023
- VRCA 2018
- Fundamental
- Price
- BMR $2.77
- VRCA $7.02
- Analyst Decision
- BMR
- VRCA Hold
- Analyst Count
- BMR 0
- VRCA 5
- Target Price
- BMR N/A
- VRCA $60.00
- AVG Volume (30 Days)
- BMR 144.3K
- VRCA 40.5K
- Earning Date
- BMR 08-19-2025
- VRCA 08-12-2025
- Dividend Yield
- BMR N/A
- VRCA N/A
- EPS Growth
- BMR N/A
- VRCA N/A
- EPS
- BMR N/A
- VRCA N/A
- Revenue
- BMR $3,064,000.00
- VRCA $7,179,000.00
- Revenue This Year
- BMR $21.21
- VRCA $165.25
- Revenue Next Year
- BMR N/A
- VRCA $80.06
- P/E Ratio
- BMR N/A
- VRCA N/A
- Revenue Growth
- BMR 5.33
- VRCA N/A
- 52 Week Low
- BMR $1.86
- VRCA $3.82
- 52 Week High
- BMR $6.59
- VRCA $58.20
- Technical
- Relative Strength Index (RSI)
- BMR 34.46
- VRCA 55.20
- Support Level
- BMR $2.75
- VRCA $5.29
- Resistance Level
- BMR $2.93
- VRCA $6.48
- Average True Range (ATR)
- BMR 0.18
- VRCA 0.58
- MACD
- BMR -0.06
- VRCA 0.02
- Stochastic Oscillator
- BMR 8.85
- VRCA 75.56
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.